Condition: Krabbe Disease · Sponsor: State University of New York at Buffalo
The purpose of this study is to develop a clinical database of individuals diagnosed with Krabbe disease in order to determine which symptoms herald the onset of clinical disease in the various phenotypes of Krabbe disease; to determine whether level of GALC enzyme activity, or a specific genetic mutation predict the clinical course; and to determine which neurodiagnostic tests predict onset and/or severity of the disease.
This description comes directly from the study's public registry record.
Thomas J. Langan, MD · 716-888-4732 · tjlangan@buffalo.edu
Amy Barczykowski · 716-829-6101 · alp38@buffalo.edu
Always discuss trial participation with your own doctor first.
| State University of New York at Buffalo | Buffalo, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02993796